Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isere Kuiatse

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Molecular Cancer Research : MCR|February 11, 2010
Sustained c-Jun-NH2-kinase activity promotes epithelial-mesenchymal transition, invasion, and survival of breast cancer cells by regulating extracellular signal-regulated kinase activationJinhua Wang, Isere Kuiatse, Adrian V Lee, et al.
Cancer Research|May 19, 2006
Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migrationXiaojiang Cui, Hyun-Jung Kim, Isere Kuiatse, et al.
Biotechniques|August 9, 2008
Novel egg white-based 3-D cell culture systemBenny Abraham Kaipparettu, Isere Kuiatse, Bonita Tak-Yee Chan, et al.
International Journal of Cancer|July 22, 2014
Dynamic balance of multiple myeloma clonogenic side population cell percentages controlled by environmental conditionsJianguo Wen, Wenjing Tao, Isere Kuiatse, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 4, 2013
The novel anticancer agent JNJ-26854165 induces cell death through inhibition of cholesterol transport and degradation of ABCA1Richard J Jones, Dongmin Gu, Chad C Bjorklund, et al.
BMC Cancer|August 27, 2011
A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesisRobert K Dearth, Isere Kuiatse, Yu-Fen Wang, et al.
Breast Cancer Research and Treatment|March 17, 2006
The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growthJana Divisova, Isere Kuiatse, ZaWaunyka Lazard, et al.
The Journal of Biological Chemistry|October 21, 2015
The Nuclear Factor (Erythroid-derived 2)-like 2 and Proteasome Maturation Protein Axis Mediate Bortezomib Resistance in Multiple MyelomaBingzong Li, Jinxiang Fu, Ping Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
BMS-536924 reverses IGF-IR-induced transformation of mammary epithelial cells and causes growth inhibition and polarization of MCF7 cellsBeate C Litzenburger, Hyun-Jung Kim, Isere Kuiatse, et al.
Plos One|September 3, 2014
Inhibition of the MDM2 E3 Ligase induces apoptosis and autophagy in wild-type and mutant p53 models of multiple myeloma, and acts synergistically with ABT-737Dongmin Gu, Shuhong Wang, Isere Kuiatse, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Molecular Cancer Research : MCR|February 11, 2010
Sustained c-Jun-NH2-kinase activity promotes epithelial-mesenchymal transition, invasion, and survival of breast cancer cells by regulating extracellular signal-regulated kinase activationJinhua Wang, Isere Kuiatse, Adrian V Lee, et al.
Cancer Research|May 19, 2006
Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migrationXiaojiang Cui, Hyun-Jung Kim, Isere Kuiatse, et al.
Biotechniques|August 9, 2008
Novel egg white-based 3-D cell culture systemBenny Abraham Kaipparettu, Isere Kuiatse, Bonita Tak-Yee Chan, et al.
International Journal of Cancer|July 22, 2014
Dynamic balance of multiple myeloma clonogenic side population cell percentages controlled by environmental conditionsJianguo Wen, Wenjing Tao, Isere Kuiatse, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 4, 2013
The novel anticancer agent JNJ-26854165 induces cell death through inhibition of cholesterol transport and degradation of ABCA1Richard J Jones, Dongmin Gu, Chad C Bjorklund, et al.
BMC Cancer|August 27, 2011
A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesisRobert K Dearth, Isere Kuiatse, Yu-Fen Wang, et al.
Breast Cancer Research and Treatment|March 17, 2006
The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growthJana Divisova, Isere Kuiatse, ZaWaunyka Lazard, et al.
The Journal of Biological Chemistry|October 21, 2015
The Nuclear Factor (Erythroid-derived 2)-like 2 and Proteasome Maturation Protein Axis Mediate Bortezomib Resistance in Multiple MyelomaBingzong Li, Jinxiang Fu, Ping Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
BMS-536924 reverses IGF-IR-induced transformation of mammary epithelial cells and causes growth inhibition and polarization of MCF7 cellsBeate C Litzenburger, Hyun-Jung Kim, Isere Kuiatse, et al.
Plos One|September 3, 2014
Inhibition of the MDM2 E3 Ligase induces apoptosis and autophagy in wild-type and mutant p53 models of multiple myeloma, and acts synergistically with ABT-737Dongmin Gu, Shuhong Wang, Isere Kuiatse, et al.
Pageof 3